1/50
Comprehensive vocabulary flashcards covering lysosomes, human lysosomal storage diseases, proteasomes, mitochondrial architecture and apoptosis, chemiosmotic ATP synthesis, chloroplast biology, and extracellular matrix adhesion molecules.
Acid Phosphatase
The characteristic marker enzyme of lysosomes; a single membrane-bound organelle that stains positively for this enzyme is identified as a lysosome.
Heterophagy
The degradation of extracellular material taken up by a cell, which involves primary lysosomes prior to membrane fusion and secondary lysosomes formed after fusion.
Phagocytosis
A sub-category of heterophagy involving the eating/engulfment of external material like bacteria; identified by Rudolph Virchow in the 1860s and named by Elie Metchnikoff from the Greek 'phago' (eat) and 'kytos' (cavity cell).
Autophagy
It eats/engulfs something inside the same cell it is eating. A catabolic pathway for lysosome-regulated organelle renewal and cellular component recycling, for which Yoshinor Ohsumi was awarded the Nobel Prize in 2016. He said that cells use autophagy to destroy and recycle cellular components.
Mitophagy
The selective autophagic degradation of mitochondria (which have a half-life of 5–6 days) mediated by PINK1 and parkin, where an autophagic vesicle forms from a cup-shaped structure containing ATG12, ATG5, ATG16, and ATG8.

Chloroquine
A lysosomotropic agent that selectively enters lysosomal cells and accumulates in lysosomes, raising internal pH from 5 to 7 to inhibit hydrolytic enzymes and sensitize chemo-resistant cancer cells to cisplatin. An example is cisplatin which is tolerated by cancer cells but are toxic to normal cells which when chloroquine is added it makes it more sensitive to chemo drugs.
Acrosome
A specialized, highly differentiated lysosomal organelle located at the tip of a sperm cell that stains positive for acid phosphatase and contains hydrolytic enzymes to break down the outer membrane of an egg.
Myasthenia Gravis
A neuromuscular autoimmune disorder characterized by autoantibodies that bind and destroy acetylcholine (ACH) receptors at the neuromuscular junction, impairing muscle contraction. It is caused by a decreased # of ACH-R.
Acetylcholinesterase is an enzyme that breaks down ACH
Curare is the first drug that was tested it clocks the ACH receptors but MG patients are very sensitive to it
Eserine was the second drug, it blocks ACH receptors and got rid of the MG symptoms
MEPPs contributed to the change of membrane potential due to MCH fusing
Dan Drachmann - used 3H-alpha-bungero toxin to bing with high affinity to ACH-R and using ultrastructural radiography hue determined that MG is caused by a low number of ACH-R
Electroplax- is the experiment with the Mice that showed that MG is an autoimmune disease
Silicosis
An environmental lung disease in miners where inhaled sharp silica particles engulfed by macrophages puncture secondary lysosomes, leaking hydrolytic enzymes that cause cell death, constitutive collagen secretion, and fibrosis.

Tay-Sachs Disease
A hereditary lysosomal storage disease prevalent in Ashkenazi Jewish populations caused by a defect in hexosaminidase A, leading to toxic accumulation of ganglioside GM2, a retinal cherry red spot, and fatal infant neurodegeneration.
Hurler's Disease
A hereditary mucopolysaccharidosis (type 1) caused by a deficiency in alpha-L iduronidase, leading to large lysosomes engorged with undegraded glycosaminoglycans; treated with enzyme replacement therapy via aldurazyme.
Inclusion (I) Cell Disease
A rare (1:700,000) lysosomal disorder caused by defective N-acetylglucosamine phosphotransferase in the cis-Golgi, preventing proper targeting tag addition and resulting in lysosomes lacking hydrolytic enzymes.
Gaucher's Disease
A hereditary lysosomal storage disease resulting from a deficiency in glucocerebrosidase, causing sphingolipid accumulation, spleen enlargement, and bone defects; treated with Cerezyme enzyme replacement therapy.
Pompe's Disease
A lysosomal storage disease caused by the lack of acid alpha-glucosidase, which prevents the release of glucose from glycogen in muscles and results in glycogen accumulation and hypoglycemia.
Proteasome
A non-organelle macromolecular protein degradation complex of approximately 750,000 Daltons (30,000–40,000 per cell) that selectively breaks down ubiquitinated proteins to regulate the cell cycle, apoptosis, and UPR.
Velcade
A clinically approved proteasome inhibitor (bortezomib) used as a chemotherapy agent to treat myeloma by exploiting cancer cells' heightened sensitivity to proteasome inhibition.
Porin
A large aqueous channel protein found in the outer mitochondrial membrane that permits the free passage of molecules smaller than 5,000 Da.
PIGBOS
A 54 aa microprotein located on the outer mitochondrial membrane that interacts with the endoplasmic reticulum to regulate unfolded protein response (UPR) stress signaling.
Cardiolipin (CL)
An inner mitochondrial membrane-specific phospholipid with 4 fatty acid acyl chains that seals the membrane against ion leakage, anchors electron transport chain complexes, and enhances transmembrane electrical resistance.
MICOS
A protein complex situated at the cristae junction of the inner mitochondrial membrane that establishes and maintains membrane curvature between boundary membranes and cristae folds.
Mitochondrial Permeability Transition Pore (MPTP)
An inner mitochondrial membrane pore complex that remains closed under normal conditions via Bcl-2 and Bcl-X, but opens under cellular stress through BAK and BAX to initiate the intrinsic apoptotic cascade.
Apoptotic Cascade (Mitochondrial)
The intrinsic cell suicide pathway triggered when MPTP opening allows cytochrome c to escape into the cytoplasm, where it binds APAF1 to activate procaspase 9, which subsequently cleaves procaspase 3 into executor caspase 3.

Venetoclax (Venclexta)
An FDA-approved small molecule specific inhibitor of anti-apoptotic Bcl-2 used to treat patients with chronic lymphocytic leukemia (CLL).
Warburg Effect
The metabolic shift seen in cancer cells where glycolysis is heavily upregulated to produce ATP even under conditions with available oxygen, accompanied by overexpression of GLUT 1, GLUT 3, PFK, and LDH.
Malate-Aspartate Shuttle
A cyclical transport system across the inner mitochondrial membrane where malate and aspartate cycle clockwise while glutamate and alpha-ketoglutarate cycle counter-clockwise to transfer cytosolic NADH reducing equivalents into matrix NADH.

Chemiosmosis
The mechanism demonstrated by Peter Mitchell (1978 Nobel Prize) in which high-energy electron flow powers proton pumping to generate an electrochemical gradient across a semi-permeable membrane that drives ATP synthesis.
Proton Motive Force (PMF)
The electrochemical potential energy stored in the transmembrane proton concentration and voltage gradient across the inner mitochondrial membrane, utilized by ATP synthase to convert ADP and Pi into ATP.
DNP (dinitrophenol)
A weak lipid-soluble acid and chemical uncoupler that dissipates the inner mitochondrial membrane proton gradient, uncoupling the ETC from ATP synthesis and releasing energy as lethal excessive heat.
Thermogenin (UCP-1)
A physiological mitochondrial uncoupling protein found in brown adipose tissue of newborns that generates heat through non-shivering thermogenesis via second messenger activation.
JC-1
A vital fluorescent dye used to monitor mitochondrial membrane potential and proton motive force, shifting from green in inactive mitochondria to orange in actively respiring mitochondria.
Positive Aerotaxis
The directed migration of motile bacteria toward an oxygen source, demonstrated by Theodore Engelman when bacteria congregated along algal chloroplast regions illuminated with red and violet wavelengths.

Photoinhibition
The light-induced loss of photosynthetic efficiency occurring when excess bright light damages the D1 protein (32,000 Daltons) of photosystem II (PSII), requiring chaperone proteins and HSP70 for recovery.
RUBISCO
The primary enzyme of the Calvin cycle and the most abundant protein on Earth, known for its slow catalytic rate and low affinity for CO2, which leads to competitive photorespiration under low CO2 and high O2 levels.
EpiDerm
A bioengineered human skin tissue grown on an extracellular matrix scaffold consisting of a Type 1 collagen gel supplemented with FCS and cross-linked with glutaraldehyde.
Cadherins
Calcium-dependent, homophilic cell adhesion molecules in adherens junctions that form cis and trans configurations between adjacent cells and anchor to the actin cytoskeleton.
E-Cadherin Junction Complex
An epithelial adherens junction assembly where homophilic E-cadherin extracellular domains link through their cytosolic tails to beta-catenin, alpha-catenin, and p120-catenin to anchor to F-actin filaments.

N-CAM
An immunoglobulin superfamily cell adhesion molecule on neuronal surfaces whose embryonic form contains high amounts of polysialic acid and large hydration shells, causing it to migrate higher on Western blots than adult forms.
Interstitium
A compressible fluid-filled anatomical compartment supported by bundles of collagen and elastin that acts as a mechanical shock absorber around organs and serves as a major source of lymph.
Corneal Endothelium
A non-dividing monolayer of cells bordering Descemet's membrane in the human eye responsible for maintaining osmotic balance and stroma clarity; damage to these cells leads to corneal cataracts.
Collagen
The most abundant fibrous animal protein, composed of a triple helix with repeating glycine residues at every third position (gly-pro-X) that provides tensile strength against mechanical stretching.
Lysyl Oxidase
An extracellular cross-linking enzyme that mediates the final covalent assembly of collagen fibers after propeptide cleavage outside the cell.
Glycosaminoglycans (GAGs)
Long, unbranched polysaccharide chains of repeating disaccharide units with dense negative charges that create large hydration shells, attract cations, resist compressive forces, and bind CD44 receptors.
Syndecans
Cell-surface proteoglycans that bind fibronectin and FGF; hypothalamic overexpression of syndecan 1 in animal models results in obesity.
Fibronectin
A multi-adhesive dimeric ECM glycoprotein involved in wound healing and digital morphogenesis that binds integrin receptors; notably down-regulated or absent in cancer cell secretomes.
Laminin
A multi-adhesive heterotrimeric glycoprotein of approximately 800 kDa that self-assembles into sheet-like networks within the basal lamina and strongly promotes neuronal differentiation and outgrowth.
Integrin Receptors
Transmembrane heterodimeric (α/β) adhesion receptors requiring divalent cations (Mg2+) that cluster into focal adhesion plaques, bind the RGD peptide sequence on ECM ligands, and link indirectly to F-actin.
Anoikis
A specialized subtype of apoptosis (from the Greek for 'homeless') triggered in substrate-dependent cells following the loss of integrin-mediated attachment to the extracellular matrix.

Extravasation
The transendothelial migration of circulating leukocytes into infected peripheral tissue, driven by leukocyte beta 2 integrin binding to endothelial ICAM molecules.
Leukocyte Adhesion Deficiency Disease
A genetic immunodeficiency disorder caused by defective or absent beta 2 integrin expression, preventing leukocyte extravasation across capillaries and leading to persistent bacterial infections.
Duchenne Muscular Dystrophy
An X-linked recessive disorder occurring in 1/7,000 males characterized by defective dystrophin, which fails to bridge the intracellular F-actin cytoskeleton to extracellular laminin 2 in the basal lamina.
Osteogenesis Imperfecta
A genetic brittle bone disorder caused by collagen abnormalities, divided into Type 1 (reduced synthesis of normal collagen fibers) and Type 2 (production of structurally malformed collagen).